Sabby Management, LLC
- SEC CIK
- 0001535610
- Latest filing
- Aug 14, 2026
ATXI holding history
Avenue Therapeutics, Inc. in every 13F filed by Sabby Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ATXI overviewAll 13F holders of ATXIFull Q2 2026 holdings
- Shares (Q4 2024)
- 0
- Sold out in Q4 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2024 | 0 | $0 | 0.0% | −63,060−100.0% | Sold out | Holders |
| Q3 2024 | 63,060 | $157.0K | 2.2% | +25,666+68.6% | Added | Holders |
| Q2 2024 | 37,394 | $130.9K | 1.7% | −633,532−94.4% | Reduced | Holders |
| Q1 2024 | 670,926 | $99.0K | 0.6% | +670,926 | New | Holders |
| Q3 2023 | 0 | $0 | 0.0% | −553,338−100.0% | Sold out | Holders |
| Q2 2023 | 553,338 | $647.4K | 2.3% | +273,440+97.7% | Added | Holders |
| Q1 2023 | 279,898 | $326.1K | 1.2% | +15,898+6.0% | Added | Holders |
| Q4 2022 | 264,000 | $306.2K | 0.8% | +264,000 | New | Holders |